98 related articles for article (PubMed ID: 28375531)
1. [Metastatic ability occurs already early on in pancreatic cancer].
Andersson R
Lakartidningen; 2017 Apr; 114():. PubMed ID: 28375531
[TBL] [Abstract][Full Text] [Related]
2. Distant metastasis occurs late during the genetic evolution of pancreatic cancer.
Yachida S; Jones S; Bozic I; Antal T; Leary R; Fu B; Kamiyama M; Hruban RH; Eshleman JR; Nowak MA; Velculescu VE; Kinzler KW; Vogelstein B; Iacobuzio-Donahue CA
Nature; 2010 Oct; 467(7319):1114-7. PubMed ID: 20981102
[TBL] [Abstract][Full Text] [Related]
3. The pathology and genetics of metastatic pancreatic cancer.
Yachida S; Iacobuzio-Donahue CA
Arch Pathol Lab Med; 2009 Mar; 133(3):413-22. PubMed ID: 19260747
[TBL] [Abstract][Full Text] [Related]
4. The patterns and dynamics of genomic instability in metastatic pancreatic cancer.
Campbell PJ; Yachida S; Mudie LJ; Stephens PJ; Pleasance ED; Stebbings LA; Morsberger LA; Latimer C; McLaren S; Lin ML; McBride DJ; Varela I; Nik-Zainal SA; Leroy C; Jia M; Menzies A; Butler AP; Teague JW; Griffin CA; Burton J; Swerdlow H; Quail MA; Stratton MR; Iacobuzio-Donahue C; Futreal PA
Nature; 2010 Oct; 467(7319):1109-13. PubMed ID: 20981101
[TBL] [Abstract][Full Text] [Related]
5. [Metastasis of pancreatic tumors].
Häberle L; Braren R; Schlitter AM; Esposito I
Pathologe; 2015 Nov; 36 Suppl 2():176-80. PubMed ID: 26391249
[TBL] [Abstract][Full Text] [Related]
6. The evolution of tumor metastasis during clonal expansion with alterations in metastasis driver genes.
Yamamoto KN; Nakamura A; Haeno H
Sci Rep; 2015 Oct; 5():15886. PubMed ID: 26515895
[TBL] [Abstract][Full Text] [Related]
7. Patterns of EphA2 protein expression in primary and metastatic pancreatic carcinoma and correlation with genetic status.
Mudali SV; Fu B; Lakkur SS; Luo M; Embuscado EE; Iacobuzio-Donahue CA
Clin Exp Metastasis; 2006; 23(7-8):357-65. PubMed ID: 17146615
[TBL] [Abstract][Full Text] [Related]
8. Tumor size significantly correlates with postoperative liver metastases and COX-2 expression in patients with resectable pancreatic cancer.
Matsumoto G; Muta M; Tsuruta K; Horiguchi S; Karasawa K; Okamoto A
Pancreatology; 2007; 7(2-3):167-73. PubMed ID: 17592230
[TBL] [Abstract][Full Text] [Related]
9. Unique patterns of metastases in common and rare types of malignancy.
Leong SP; Nakakura EK; Pollock R; Choti MA; Morton DL; Henner WD; Lal A; Pillai R; Clark OH; Cady B
J Surg Oncol; 2011 May; 103(6):607-14. PubMed ID: 21480255
[TBL] [Abstract][Full Text] [Related]
10. Serum CA19-9 determination in the management of pancreatic cancer.
van den Bosch RP; van Eijck CH; Mulder PG; Jeekel J
Hepatogastroenterology; 1996; 43(9):710-3. PubMed ID: 8799418
[TBL] [Abstract][Full Text] [Related]
11. Survival in pancreatic carcinoma based on tumor size.
Agarwal B; Correa AM; Ho L
Pancreas; 2008 Jan; 36(1):e15-20. PubMed ID: 18192868
[TBL] [Abstract][Full Text] [Related]
12. Update on the management of pancreatic cancer: surgery is not enough.
Ansari D; Gustafsson A; Andersson R
World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
[TBL] [Abstract][Full Text] [Related]
13. MAL2 expression predicts distant metastasis and short survival in pancreatic cancer.
Eguchi D; Ohuchida K; Kozono S; Ikenaga N; Shindo K; Cui L; Fujiwara K; Akagawa S; Ohtsuka T; Takahata S; Tokunaga S; Mizumoto K; Tanaka M
Surgery; 2013 Sep; 154(3):573-82. PubMed ID: 23876361
[TBL] [Abstract][Full Text] [Related]
14. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
15. Advancements in the management of pancreatic cancer: 2013.
Saif MW
JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
[TBL] [Abstract][Full Text] [Related]
16. Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma.
Ansari D; Bauden M; Bergström S; Rylance R; Marko-Varga G; Andersson R
Br J Surg; 2017 Apr; 104(5):600-607. PubMed ID: 28177521
[TBL] [Abstract][Full Text] [Related]
17. Key biological processes driving metastatic spread of pancreatic cancer as identified by multi-omics studies.
Le Large TYS; Bijlsma MF; Kazemier G; van Laarhoven HWM; Giovannetti E; Jimenez CR
Semin Cancer Biol; 2017 Jun; 44():153-169. PubMed ID: 28366542
[TBL] [Abstract][Full Text] [Related]
18. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases.
Guo X; Friess H; Graber HU; Kashiwagi M; Zimmermann A; Korc M; Büchler MW
Cancer Res; 1996 Nov; 56(21):4876-80. PubMed ID: 8895737
[TBL] [Abstract][Full Text] [Related]
19. Cancer: Genomic evolution of metastasis.
Luebeck EG
Nature; 2010 Oct; 467(7319):1053-5. PubMed ID: 20981088
[No Abstract] [Full Text] [Related]
20. Measurement of copy number of ACTN4 to optimize the therapeutic strategy for locally advanced pancreatic cancer.
Shoji H; Miura N; Ueno H; Honda K
Pancreatology; 2018 Sep; 18(6):624-629. PubMed ID: 29921500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
